Literature DB >> 9546358

Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system.

S Jander1, J Pohl, D D'Urso, C Gillen, G Stoll.   

Abstract

Experimental autoimmune encephalomyelitis of the Lewis rat is a T-cell-mediated autoimmune disease of the central nervous system characterized by a self-limiting monophasic course. In this study, we analyzed the expression of the anti-inflammatory cytokine interleukin (IL)-10 at the mRNA and protein level in experimental autoimmune encephalomyelitis actively induced with the encephalitogenic 68-86 peptide of guinea pig myelin basic protein. Semiquantitative reverse transcriptase-polymerase chain reaction revealed that IL-10 mRNA expression peaked during the acute phase of the disease at days 11 and 13. IL-10 mRNA was synchronously induced with mRNA for the proinflammatory cytokine interferon-gamma. Immunocytochemistry with a monoclonal antibody against rat IL-10 showed that the peak of IL-10 mRNA was accompanied by an abundant expression of IL-10 protein during the acute stage of the disease. Both in situ hybridization and double labeling immunocytochemistry in combination with confocal microscopy identified T cells, macrophages/microglia, and astrocytes as major cellular sources of IL-10 in vivo. The early peak of IL-10 production was unexpected in light of its well-documented anti-inflammatory properties. Additional studies are required to determine whether endogenous IL-10 contributes to rapid clinical remission typical for Lewis rat experimental autoimmune encephalomyelitis or if it plays other, yet undefined, roles in central nervous system autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546358      PMCID: PMC1858238     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

Authors:  L Ding; P S Linsley; L Y Huang; R N Germain; E M Shevach
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

2.  Experimental allergic encephalomyelitis.

Authors:  R H Swanborg
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.

Authors:  X F Bai; J Zhu; G X Zhang; G Kaponides; B Höjeberg; P H van der Meide; H Link
Journal:  Clin Immunol Immunopathol       Date:  1997-05

Review 4.  Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

Authors:  C S Raine
Journal:  Lab Invest       Date:  1984-06       Impact factor: 5.662

5.  Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis.

Authors:  G Stoll; S Müller; B Schmidt; P van der Meide; S Jung; K V Toyka; H P Hartung
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

6.  Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery.

Authors:  M K Kennedy; D S Torrance; K S Picha; K M Mohler
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

7.  Synthesis and characterization of rat interleukin-10 (IL-10) cDNA clones from the RNA of cultured OX8- OX22- thoracic duct T cells.

Authors:  R E Goodman; J Oblak; R G Bell
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

8.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

Authors:  R de Waal Malefyt; J Haanen; H Spits; M G Roncarolo; A te Velde; C Figdor; K Johnson; R Kastelein; H Yssel; J E de Vries
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Avijit Ray; Sreemanti Basu; Christopher L Karp; Bonnie N Dittel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

2.  Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.

Authors:  B Serafini; S Columba-Cabezas; F Di Rosa; F Aloisi
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 3.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

5.  Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

Authors:  Herena Eixarch; Carmen Espejo; Alba Gómez; María José Mansilla; Mireia Castillo; Alexander Mildner; Francisco Vidal; Ramón Gimeno; Marco Prinz; Xavier Montalban; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

6.  CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction.

Authors:  Michael Schroeter; Guido Stoll; Robert Weissert; Hans-Peter Hartung; Hans Lassmann; Sebastian Jander
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Interleukin-10 provides direct trophic support to neurons.

Authors:  Zhigang Zhou; Xiangmin Peng; Ryan Insolera; David J Fink; Marina Mata
Journal:  J Neurochem       Date:  2009-07-02       Impact factor: 5.372

8.  Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.

Authors:  Alejandro M S Mayer; Joseph Murphy; David MacAdam; Christopher Osterbauer; Imaan Baseer; Mary L Hall; Domonkos Feher; Phillip Williams
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

9.  PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.

Authors:  Yoshihiro Wada; Tomoya Nakamachi; Kimi Endo; Tamotsu Seki; Hirokazu Ohtaki; Daisuke Tsuchikawa; Motohide Hori; Masashi Tsuchida; Akira Yoshikawa; Attila Matkovits; Nobuyuki Kagami; Nori Imai; Shiho Fujisaka; Isao Usui; Kazuyuki Tobe; Ryohei Koide; Haruo Takahashi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2013-05-30       Impact factor: 3.444

Review 10.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Authors:  Lisa Fellner; Kurt A Jellinger; Gregor K Wenning; Nadia Stefanova
Journal:  Acta Neuropathol       Date:  2011-05-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.